Arterial and End-Tidal CO2 Gradient as a Mortality Predictor in Critical Care Patients

Sponsor
Gaziosmanpasa Research and Education Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT05341258
Collaborator
(none)
50
1
1
7
7.2

Study Details

Study Description

Brief Summary

Scoring systems (SOFA, APACHE-II etc.) are used to estimate the mortality rates of patients treated in the intensive care unit. . In the scoring systems used, the disfunction level of the organs of the patients is measured. Blood gas analysis is routinely performed in patients whom intubated in the intensive care unit and receiving mechanical ventilation support, and the patient's treatment is optimized according to the results of the examination. The patient's mechanical ventilation settings are regulated by analyzing the Partial Arterial Carbondioxide (paCO2) value in the patient's blood gas result. The difference between the paCO2 value in the blood gas and the End-tidal Carbondioxide (EtCO2) value measured in the mechanical ventilator is 3-5mmHg in normal healthy people, while this difference is seen more in critical care patients. In critically ill patients in the intensive care unit, there is a greater increase in the difference between paCO2 and ETCO2 in cases where mortality is high, such as global perfusion disorder, shock situations, and massive pulmonary embolism, etc. In this study, it was planned to investigate the use of the difference between the paCO2 value in the blood gas taken from the patient and the ETCO2 value measured in the mechanical ventilator to predict the mortality rate of the patient.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: EtCO2
  • Diagnostic Test: PaCO2
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
50 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Arterial and End-Tidal CO2 Gradient as a Mortality Predictor in Critical Care Patients
Actual Study Start Date :
Jan 1, 2022
Actual Primary Completion Date :
Aug 1, 2022
Actual Study Completion Date :
Aug 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Other: Critical Care Patients whom intubated last 24 hours

Critical Care Patients whom intubated last 24 hours

Diagnostic Test: EtCO2
EtCO2

Diagnostic Test: PaCO2
PaCO2

Outcome Measures

Primary Outcome Measures

  1. Mortality [6 months]

    Evaluation of correlation between PaCO2 and ETCO2 gradient difference and mortality in intubated critical care patients and mortality rates

Secondary Outcome Measures

  1. ICU Length of Stay [6 months]

    Days patients treated at ICU

  2. Ventilator Free Days [6 months]

    Days during which the patient was mechanically ventilated

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Critical Care Patients intubated in last 24 hours.
Exclusion Criteria:
  • Patients younger than 18 years old.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Gaziosmanpasa Training Research Hospital Istanbul Turkey 34255

Sponsors and Collaborators

  • Gaziosmanpasa Research and Education Hospital

Investigators

  • Study Director: Ulku Aygen Turkmen, Proffessor, Director of Anesthesiology and Reanimation Department

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Gaziosmanpasa Research and Education Hospital
ClinicalTrials.gov Identifier:
NCT05341258
Other Study ID Numbers:
  • 3751
First Posted:
Apr 22, 2022
Last Update Posted:
Aug 24, 2022
Last Verified:
Nov 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 24, 2022